BackZhengye Biotechnology Holding Limited Overview

Zhengye Biotechnology Holding Limited Current Cash

Track Zhengye Biotechnology Holding Limited's current cash ($50M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$50.33M
↑ 170.54% YoYΔ $31.73M vs prior year quarter

Peer trimmed avg / median

Loading

Zhengye Biotechnology Holding Limited Current Cash History

Loading

Zhengye Biotechnology Holding Limited vs. peers: Current Cash Comparison

Loading

Zhengye Biotechnology Holding Limited Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Zhengye Biotechnology Holding Limited (ZYBT) FAQ

As of the most recent data (December 2025), ZYBT shows a current cash of $50M. That compares with $19M in the prior-year period — up 170.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ZYBT's current cash is now $50M (was $19M) — a 170.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Zhengye Biotechnology Holding Limited is outperforming or lagging.

Tracking ZYBT's current cash over time shows whether Zhengye Biotechnology Holding Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $50M That compares with $19M in the prior-year period — up 170.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Zhengye Biotechnology Holding Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $50M) with ownership activity and broader fundamentals.